Latest Breaking News On - Breast cancer research executive committee - Page 1 : comparemela.com

NATALEE Data Shows Ribociclib Reduces Risk of Recurrence for High-Risk Node-Negative Early Breast Cancer

The addition of ribociclib (Kisqali; Novartis) to endocrine therapy demonstrated a 28% risk reduction in invasive disease-free survival.

United-states
American
Sebastian-kaulitzki
Denisea-yardley
Jeff-legos
Aimee-keegan
Sarah-cannon-research-institute
Breast-cancer-research-executive-committee
Global-head-of-oncology-development
European-medicines-agency
American-society-of-clinical-oncology
Novartis

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease

Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Barcelona
Comunidad-autonoma-de-cataluna
Spain
Switzerland
Paris
France-general
France
Texas
United-states
Chicago
Illinois
Lugano

Menarini Industrie Farmaceutiche Riunite: Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

Menarini Industrie Farmaceutiche Riunite: Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Winterhof
Nordrhein-westfalen
Germany
Italy
United-states
American
Elcin-barker-ergun
Elacestrant-clinical-development-program
Breast-cancer-research
Menarini-group
University-of-california-san-francisco
American-society-of-clinical-oncology

Arvinas, Pfizer Update Phase 1b Trial Data for Vepdegestrant, Palbociclib

Arvinas, Pfizer Update Phase 1b Trial Data for Vepdegestrant, Palbociclib
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Nashville
Tennessee
United-states
Noah-berkowitz
Roger-dansey
Arvinas-inc
Breast-cancer-research
Breast-cancer-annual-congress
Drug-administration
Sarah-cannon-research-institute-in-nashville
Breast-cancer-research-executive-committee
Nasdaq

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)

Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Nashville
Tennessee
United-states
New-york
Jeff-boyle
Roger-dansey
Noah-berkowitz
Kathleen-murphy
Nasdaq
Breast-cancer-annual-congress
Sarah-cannon-research-institute-in-nashville
Pfizer